MediGene AG has appointed Dolores Schendel as chief scientific officer. Former Director of the Institute of Molecular Immunology at the Helmholtz-Zentrum Munchen and Managing Director of Trianta Immunotherapies GmbH, Prof. Schendel will now be the Executive Board member responsible for R&D at Medigene. She will continue as Member of the Management Board of Trianta Immunotherapies GmbH, which was acquired by Medigene in January 2014.